Mediclinic Welcare Hospital was the first hospital in the MENA region to offer iTind – an advanced and minimally invasive procedure for the enlarged prostate.

Benign prostatic hyperplasia, or BPH, is a noncancerous enlargement of the prostate gland, and the most common benign tumour found in men. This causes the prostate to press against the urethra, causing chronic and sometimes troublesome lower urinary tract symptoms that can severely affect your quality of life. If a man has been diagnosed with an enlarged prostate due to BPH, it is important to be monitored by an urologist.

The iTind is a temporarily implanted device which delivers rapid and effective relief from BPH symptoms through minimally invasive treatment. The iTind device is inserted into the prostatic urethra via a cystoscope during the 15-minute-long procedure under anaesthesia. Once in place, the mind expands and exerts continuous pressure on the prostatic urethra and the bladder neck at the 5, 7 and 12 o’clock positions. Then it remodels the tissue by creating three deep longitudinal channels. These three channels then allow urine to flow better. Patients can return home and after the implantation period of 5-7 days, the device is completely removed.